Gladstone NOW: The Campaign Join Us on the Journey✕
Douglas Melton, PhD, co-director of the Harvard Stem Cell Institute, was awarded the prize for his work to treat diabetes with insulin-producing pancreatic cells created from stem cells.
The Ogawa-Yamanaka Stem Cell Prize celebrates scientists whose original translational research has advanced cellular reprogramming technology for regenerative medicine.
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
The prize, issued annually to eight scientists, seeks to catalyze high-impact neuroscience research.
Awards News Release Alzheimer’s Disease Neurological Disease Corces Lab AIRoan has made great strides in understanding how persistent viruses including HIV cause disease and how immunity to viruses shapes human health.
Awards News Release COVID-19 HIV/AIDS Infectious Disease Roan LabAmong his myriad accomplishments, Rudolf Jaenisch—winner of the 2025 Ogawa-Yamanaka Stem Cell Prize—was the first to demonstrate the potential of induced pluripotent stem cells to treat disease.
Awards Ogawa Stem Cell Prize Profile Regenerative Medicine Stem Cells/iPSCs